Bausch & Lomb Inc - Company Profile
Powered by 
All the data and insights you need on Bausch & Lomb Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Bausch & Lomb Inc Strategy Report
- Understand Bausch & Lomb Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Bausch Health Companies Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It provides over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as conjunctivitis, glaucoma, eye allergies, dry eye and retinal diseases. It has presence across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.
Headquarters
United States of America
Address
400 Somerset Corporate Boulevard, Bridgewater, New Jersey, 08807
Website
www.bausch.com
Telephone
1 866 2468245
No of Employees
12,000
Industry
Medical Equipment
Bausch & Lomb Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Products | PreserVision |
| Contact Lenses: | Ocuvite |
| Lenses for Nearsighted/Farsighted | Lotemax |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Asset Purchase | In September, the company acquired 'front of eye' ophthalmology assets from Novartis. |
| 2023 | Acquisitions/Mergers/Takeovers | In July, the company acquired Johnson & Johnson eye and contact lens drops brand, Blink for US$106.5 million. |
| 2023 | Contracts/Agreements | In July, the company signed an agreement to acquire dry eye drug Xiidra from Novartis. |
Competitor Comparison
| Key Parameters | Bausch & Lomb Inc | EssilorLuxottica SA | Carl Zeiss Meditec AG | Harrow Inc | Abbott Medical Optics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | France | Germany | United States of America | United States of America |
| City | Bridgewater | Charenton-Le-Pont | Jena | Nashville | Santa Ana |
| State/Province | New Jersey | Ile-de-France | Thuringen | Tennessee | California |
| No. of Employees | 12,000 | 191,706 | 4,823 | 315 | - |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Brent Saunders | Chief Executive Officer; Chairman | Executive Board | 2023 | - |
| Bob Bailey | Chief Legal Officer; Executive Vice President | Senior Management | 2023 | - |
| Sam Eldessouky | Chief Financial Officer; Executive Vice President | Senior Management | - | - |
| Yehia Hashad | Chief Medical Officer; Executive Vice President - Research & Development | Senior Management | - | - |
| Brett Icahn | Portfolio Manager, Icahn Capital LP | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer